How Long Do You Need to Be on Wegovy to See Results?

Wegovy (semaglutide 2.4mg) produces most of its weight loss over the first 68–72 weeks, with significant changes typically visible from week 12 onwards.
NICE recommends semaglutide for a maximum of two years within a specialist weight management service on the NHS — a limit that applies to that NHS route specifically.
Weight tends to return after stopping, particularly without sustained lifestyle changes in place; duration should be decided with your prescriber.
Titration takes roughly 16–20 weeks to reach the 2.4mg maintenance dose, so early weeks are about tolerability, not peak effect.

How long you need to be on Wegovy depends on how your body responds, but most people stay on it for at least a year — and many continue beyond that. Wegovy is a prescription-only medicine requiring ongoing clinical assessment, not a short course you finish and move on from. The honest answer: for most people, the question shifts from when do I stop to is this still working, and is it still right for me. Here's what the evidence actually says.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and UK guidance say about how long treatment lasts

You're probably six months in and wondering whether there's a finish line

That question is one our prescribers hear most weeks. You've got through the early nausea, you're on a higher dose, and the weight is moving, but nobody's told you how long this actually goes on for. It's a reasonable thing to want clarity on, and the absence of a clear answer can feel unsettling.

The short version: Wegovy isn't designed like a course of antibiotics. The STEP 1 trial, published in the New England Journal of Medicine, ran for 68 weeks and found an average weight reduction of around 15% at the 2.4mg dose. Crucially, participants who stopped semaglutide regained most of that weight within a year. The medicine works while you take it; it doesn't permanently reset your appetite biology after a fixed number of months. That shapes how long most people end up staying on it.

For people accessing Wegovy through the full Wegovy treatment overview, it helps to understand this from the outset rather than arrive at month nine expecting a taper conversation that isn't coming.

The NICE two-year limit, and what it actually applies to

You may have read that NICE recommends semaglutide for a maximum of two years. That's accurate, but the context matters. NICE's appraisal of semaglutide (TA875) applies specifically to NHS access through specialist weight management services, where the two-year cap is a commissioning boundary, not a clinical verdict on what's safe or appropriate beyond that point. NICE also advises that treatment should be reviewed if less than 5% weight loss has occurred after six months at the maintenance dose.

Private treatment follows the licensed indication in the SmPC rather than the NICE commissioning guidance. The medicine's UK licence doesn't carry an absolute time ceiling; duration is a clinical decision based on continued benefit, tolerability, and your overall health picture. That's exactly the kind of ongoing review that should happen with every repeat, the question of how long you can stay on Wegovy is explored in more detail separately.

What both routes agree on: if the medicine isn't producing meaningful weight loss, continuing it isn't appropriate. The prescriber's job (not yours) is to assess that regularly.

Titration takes time, which changes when you measure results

One reason people feel unsure about timelines is that the first few months aren't representative. The standard semaglutide titration moves from 0.25mg through 0.5mg, 1mg, and 1.7mg before reaching 2.4mg maintenance, roughly 16 to 20 weeks of gradual increases. The starter doses are about giving your digestive system time to adjust, not about maximum effect. Expecting significant weight change during titration is a setup for disappointment.

Meaningful loss typically becomes consistent from around week 12 and accelerates through months four to twelve. The curve flattens after that, which is normal and doesn't mean the medicine has stopped working. It means you've found your new setpoint. How quickly Wegovy produces noticeable results is a separate question worth reading alongside this one if you're still in the early stages.

If you're considering costs alongside duration, the UK price context for Wegovy is worth understanding before you commit to what could be a multi-year course of treatment.

What happens when you stop, and how that shapes the duration question

Stopping Wegovy is something to plan with your prescriber rather than decide unilaterally. The trial evidence is clear: in participants who discontinued after 68 weeks of treatment, roughly two-thirds of lost weight returned within a year. That isn't a failure of willpower; semaglutide reduces appetite by acting on GLP-1 receptors, and when the medicine is gone, that signal goes with it.

That said, stopping isn't always the wrong call. If you've made substantial, durable lifestyle changes alongside treatment, if your weight-related health conditions have resolved, or if the medicine is no longer producing benefit, your prescriber may agree that the evidence supports tapering off. Our guide to how long you need to take Wegovy walks through the clinical factors that typically inform that conversation. The conversation should happen with a clinician who knows your case, not based on a fixed number of months. You can read more about how long you have to stay on Wegovy to get a sense of the factors involved.

Duration is ultimately a clinical decision, made between you and a prescriber who has the full picture. If you haven't had that conversation recently, or you're still working out whether Wegovy is right for you at all, check your eligibility with our clinical team, a real prescriber reviews every consultation, no algorithm involved.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions